Transition Metal Complex‐Loaded Nanosystems: Advances in Stimuli‐Responsive Cancer Therapies
Author:
Abstract
Transition metal complex‐loaded nanosystems (TMCNs) represent a cutting‐edge platform for stimuli (light, ultrasound)‐responsive cancer therapies. These nanosystems, incorporating metals such as manganese(II), zinc(II), ruthenium(II), rhenium(I), iridium(III), and platinum(IV), significantly enhance the efficacy of light‐activated therapies, including photodynamic therapy (PDT) and photothermal therapy (PTT), as well as ultrasound‐activated treatments like sonodynamic therapy (SDT). TMCNs based on ruthenium(II), rhenium(I), and iridium(III) improve PDT, while manganese(II) and iridium(III) demonstrate exceptional sonosensitizing properties. In PTT, ruthenium(II) and iridium(III)‐based TMCNs efficiently absorb light and generate heat. Emerging synergistic approaches that combine SDT, PTT, PDT, chemotherapy, and immunotherapy are demonstrated to be powerful strategies for precision cancer treatment. Zinc(II), ruthenium(II), iridium(III), and platinum(IV)‐based TMCNs play a critical role in optimizing these therapies, enhancing tumor targeting, and reducing side effects. Furthermore, TMCNs can amplify immunotherapy by inducing immunogenic cell death, thus strengthening the immune response. These advances address key challenges such as tumor hypoxia and therapeutic resistance, opening new possibilities for innovative photosensitizer‐based cancer treatments. This review highlights the latest progress in TMCNs design and applications, demonstrating their potential to revolutionize stimuli‐responsive cancer therapies.Keywords
This publication has 105 references indexed in Scilit:
- Ir(III)‐Based Photosensitizer‐Loaded M1 Macrophage Exosomes for Synergistic Photodynamic TherapyAdvanced Functional Materials, 2024
- Expanded ROS Generation and Hypoxia Reversal: Excipient‐free Self‐assembled Nanotheranostics for Enhanced Cancer Photodynamic ImmunotherapyAdvanced Materials, 2024
- Strategies for the Nuclear Delivery of Metal Complexes to Cancer CellsAdvanced Materials, 2024
- Nanoparticle‐Based Photothermal Therapy for Breast Cancer Noninvasive TreatmentAdvanced Materials, 2023
- Organic Sonodynamic Materials for Combination Cancer ImmunotherapyAdvanced Materials, 2023
- Bifunctional Nano‐Assembly of Iridium(III) Phthalocyanine Complex Encapsulated with BSA: Hypoxia‐relieving/Sonosensitizing Effects and their Immunogenic Sonodynamic TherapyAdvanced Functional Materials, 2022
- An Iridium (III) Complex Bearing a Donor–Acceptor–Donor Type Ligand for NIR‐Triggered Dual PhototherapyAdvanced Functional Materials, 2020
- AIE Multinuclear Ir(III) Complexes for Biocompatible Organic Nanoparticles with Highly Enhanced Photodynamic PerformanceAdvanced Science, 2019
- Delivery of Phosphorescent Anticancer Iridium(III) Complexes by Polydopamine Nanoparticles for Targeted Combined Photothermal‐Chemotherapy and Thermal/Photoacoustic/Lifetime ImagingAdvanced Science, 2018
- Porous Porphyrin‐Based Organosilica Nanoparticles for NIR Two‐Photon Photodynamic Therapy and Gene Delivery in ZebrafishAdvanced Functional Materials, 2018